Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Oct 2025 for Nirvana Life Sciences In., €14k.
Filing timeline
BuySaleJakson Samuel Inwentash
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Jakson Samuel Inwentash: trading record in brief
This profile gathers the share dealings of Jakson Samuel Inwentash in Nirvana Life Sciences In. Over a trading history stretching from 8 June 2022 to 4 July 2025, the count stands at 4 filings.
No open-market sale appears; the market trades are 1 purchase worth €14k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2025, the count stands at 1 purchase and no sales.
The newest entry dates from 10 October 2025: an open-market purchase of €14k, in Nirvana Life Sciences In. The median gap between a trade and its publication by SEDI is 51 days. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.
Companies and markets linked to Jakson Samuel Inwentash
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
439,567 shares@ CA$0.05100.0% of flowCommon SharesTSXSEDI:4591320
Canonical exit: 2 Oct 2025 (T+90)
Common SharesTSXSEDI:4591319
500,000 sharesCommon SharesTSXSEDI:4533088
50,000 sharesCommon SharesTSXSEDI:4533089
4 of 4 declarations
